


James M Frates - Needham, MA | Intelius



























Sign In



We found James M Frates in Needham, MA


James M Frates

                                                                           Intelius found that James M Frates  is  a male between 50 and 50 years old from Needham, MA.  We have connected them to
                7 addresses,
                4 phones,
                and 5 relatives or associates.
         





Also Known As

James Matthew Frates


Get Report Now

Age

James M Frates is in his 50s

James Has Lived In

Needham, MA
Boston, MA
Barrington, RI

James's Relatives

Mary Frates
Richard Frates
Richard E Frates
Ann Frates







James M Frates



Zodiac SignGemini



GenderMale



Professional Status
Vice President at Alkermes



Get Report Now










Want to know more about James? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about James, or use our people search engine to find others.
Get Background Check on James M Frates
Get a Criminal Check on James M Frates
Get a Public Record Report on James M Frates
Get a People Search Report on James M Frates


James M Frates's Contact Information
Known Cities Lived In
Find out where James M Frates has lived as well as James M Frates's phone numbers and email addresses.




James M Frates Has Lived in 2 States
Massachusetts Address for James M Frates


471 G**** S* 

Needham, MA


Has Lived In

Needham, MA
Boston, MA


Get Full Address Report










Phone Numbers Associated with James M Frates

(781) ***-**** - Needham, MA 
(781) ***-**** - Wellesley Hills, MA 
(617) ***-**** - Boston, MA 


Get Full Phone Report



Email Addresses Associated with James M Frates

j*********s@***.com
j*********s@***.com
j*****s@***.net


Get Email Report




James M Frates's Professional Information
Information regarding James M Frates's professional history.  Find out previous places James M Frates has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


James M Frates Has Worked at 3 Places
Company: Alkermes
               Title: Vice President
Company: Alkermes
               Title: Treasurer
James M Frates's Experience
Title: Vice President
               Company: Alkermes
Job Details

Title: Treasurer
               Company: Alkermes
Job Details

Additional Professional Information on James M Frates

 See James M Frates's LinkedIn Profile



James M Frates's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for James M Frates


James M Frates's known Social Networks And Potential Email Matches

Find all of James M Frates's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
James Frates
Username Matches

                  JamesFrates
                  FratesJames
                  James.Frates
                  Frates.James
                  James_Frates
                  Frates_James
                  James-Frates
                  Frates-James
                  JFrates
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
J Frates







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.




















James M. Frates - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















James M. Frates
Senior Vice President, Chief Financial Officer and Treasurer at Alkermes


View Full Profile
Are you James M. Frates? Claim your profile


 


Sign up for Equilar Atlas and view James M. Frates's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in James M. Frates's  network and community.
												FOLLOW changes in James M. Frates's employment and money-in-motion.
												CONNECT with James M. Frates through your network of contacts.
												








James M. Frates's Executive Work History


Current


Senior Vice President, Chief Financial Officer and Treasurer, 
Alkermes


Past
To view James M. Frates's complete executive work history, sign up now
Education


														 B.A., 
															Harvard University


Age
49

 
 


James M. Frates's Biography



James Frates. Mr. Frates has served as a member of our Board of Directors since May 2014. He is the Senior Vice President and Chief Financial Officer of Alkermes plc, having held that position since September 2011. From 2007 to 2011, Mr. Frates served as Senior Vice President and Chief Financial Officer of Alkermes, Inc. From 1998 to 2007, Mr. Frates served as Vice President, Chief Financial Officer and Treasurer of Alkermes, Inc. From 1996 to 1998, he was employed at Robertson, Stephens & Company, most recently as a Vice President in Investment Banking. Prior to that time, he was employed at Morgan Stanley & Co. From 2004 to 2009, Mr. Frates ...
(Read More)

			James Frates. Mr. Frates has served as a member of our Board of Directors since May 2014. He is the Senior Vice President and Chief Financial Officer of Alkermes plc, having held that position since September 2011. From 2007 to 2011, Mr. Frates served as Senior Vice President and Chief Financial Officer of Alkermes, Inc. From 1998 to 2007, Mr. Frates served as Vice President, Chief Financial Officer and Treasurer of Alkermes, Inc. From 1996 to 1998, he was employed at Robertson, Stephens & Company, most recently as a Vice President in Investment Banking. Prior to that time, he was employed at Morgan Stanley & Co. From 2004 to 2009, Mr. Frates served on the board of directors of GPC Biotech AG, a biotechnology company, and was a national director of the Association of Bioscience Financial Officers from 2004 to 2009. Mr. Frates is also a Trustee of St. Paul's School and The Roxbury Latin School. We believe Mr. Frates' qualifications to sit on our Board of Directors include his leadership experience, financial expertise, business judgment and industry knowledge.
		
Source: Sage Therapeutics, Inc. on 04/13/2017
		
	

 






Sign up for Equilar Atlas and view James M. Frates's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like James M. Frates. More specifically, you'll be able to:
												

IDENTIFY corporate executives in James M. Frates's  network and community.
												FOLLOW changes in James M. Frates's employment and money-in-motion.
												CONNECT with James M. Frates through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: James M. Frates


















James M. Frates's Connections (83)





Sign up now to view James M. Frates's 83 connections »









Steven M. Paul
Dir., President and Chief Executive Officer, Voyager Therapeutics, Inc.









Kevin P. Starr
Board Member, Alnylam Pharmaceuticals, Inc.









John K. Clarke
Former Board Member, Alnylam Pharmaceuticals, Inc.









David W. Anstice
Former Executive Vice President, Strategy Initiatives, Merck & Co (Old)









Howard H. Pien
Board Member, ImmunoGen, Inc.









Metin Colpan
Former Board Member, QIAGEN N.V.









James L. Wright
Former Senior Vice President, Pharmaceutical Research and Development, Alkermes









Gordon G. Pugh
SVP, COO & CRO, Alkermes, Inc., Alkermes









Robert T. Nelsen
Former Board Member, Agios Pharmaceuticals, Inc.









Richard F. Pops
Chairman of the Board and Chief Executive Officer, Alkermes








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









David J. O'Connor
President and CEO, The Madison Square Garden Company









Claiborne P. Deming
Chairman of the Board, Murphy Oil Corporation












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993
















ALKS James M. Frates Insider Trades for Alkermes PLC


































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Alkermes PLC

                  NASDAQ: ALKS
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Alkermes PLC



After Hours
 --Quotes are delayed by 20 min
Jul 21, 2017, 4:34 p.m.


ALKS

/quotes/zigman/6688932/composite


$
57.73




Change

0.00
0.00%

Volume
Volume 15,341
Quotes are delayed by 20 min








/quotes/zigman/6688932/composite
Previous close

$
			57.53
		


$
				57.73
			
Change

+0.20
+0.35%





Day low
Day high
$57.16
$58.05










52 week low
52 week high

            $41.93
        

            $63.40
        


















Insider Activity


Individual




James M. Frates



Mr. James M. Frates is Chief Financial Officer, Treasurer & Senior VP at Alkermes Plc and Treasurer & Trustee at St Paul's School. He is on the Board of Directors at SAGE Therapeutics, Inc., Alkermes, Inc. and St Paul's School. Mr. Frates was previously employed as National Director by Association of Bioscience Financial Officers, Chief Financial Officer, Treasurer, CAO & SVP by Alkermes, Inc., Vice President-Investment Banking by BancBoston Securities, Inc., and Vice President-Investment Banking by Robertson Stephens & Co. He also served on the board at GPC Biotech AG. He received his undergraduate degree from Harvard College and an MBA from Harvard Business School.



Transactions


Date
Shares
Transaction
Value





05/28/2017
1,177


 
Derivative/Non-derivative trans. at $57.7 per share.


67,913


05/28/2017
2,500


 
Derivative/Non-derivative trans. at $0 per share.


0


03/07/2017
400


 
Disposition at $59.57 per share.


23,828


03/07/2017
24,600


 
Disposition at $59.07 per share.


1,453,122


03/07/2017
25,000


 
Derivative/Non-derivative trans. at $16.55 per share.


413,750


03/03/2017
913


 
Derivative/Non-derivative trans. at $60.97 per share.


55,666


03/03/2017
2,812


 
Derivative/Non-derivative trans. at $0 per share.


0


03/01/2017
1,461


 
Derivative/Non-derivative trans. at $59.71 per share.


87,237


03/01/2017
4,500


 
Derivative/Non-derivative trans. at $0 per share.


0


02/26/2017
852


 
Derivative/Non-derivative trans. at $52.98 per share.


45,139


02/26/2017
2,625


 
Derivative/Non-derivative trans. at $0 per share.


0


12/14/2016
100


 
Disposition at $55.2 per share.


5,520


12/14/2016
24,900


 
Disposition at $54.72 per share.


1,362,528


12/14/2016
10,000


 
Derivative/Non-derivative trans. at $11.74 per share.


117,400


12/14/2016
15,000


 
Derivative/Non-derivative trans. at $14.13 per share.


211,950


12/07/2016
856


 
Disposition at $57.22 per share.


48,981


12/07/2016
17,379


 
Disposition at $56.44 per share.


980,871


12/07/2016
5,496


 
Disposition at $55.65 per share.


305,853


12/07/2016
10,000


 
Derivative/Non-derivative trans. at $11.74 per share.


117,400


12/07/2016
13,731


 
Derivative/Non-derivative trans. at $15.95 per share.


219,009


11/18/2016
1,711


 
Derivative/Non-derivative trans. at $58.44 per share.


99,991


11/18/2016
6,042


 
Derivative/Non-derivative trans. at $16.55 per share.


99,995


10/05/2016
2,353


 
Derivative/Non-derivative trans. at $46.43 per share.


109,250


10/05/2016
5,000


 
Derivative/Non-derivative trans. at $0 per share.


0


08/04/2016
4,437


 
Gift at $0 per share.


0


05/28/2016
1,177


 
Derivative/Non-derivative trans. at $46.13 per share.


54,296


05/28/2016
2,500


 
Derivative/Non-derivative trans. at $0 per share.


0


05/21/2016
1,259


 
Derivative/Non-derivative trans. at $42.98 per share.


54,112


05/21/2016
3,750


 
Derivative/Non-derivative trans. at $0 per share.


0


03/03/2016
2,813


 
Derivative/Non-derivative trans. at $0 per share.


0


03/03/2016
23,315


 
Derivative/Non-derivative trans. at $20.79 per share.


484,718


02/26/2016
2,625


 
Derivative/Non-derivative trans. at $0 per share.


0


11/24/2015
1,346


 
Derivative/Non-derivative trans. at $74.26 per share.


99,954


11/24/2015
5,523


 
Derivative/Non-derivative trans. at $18.11 per share.


100,021


11/10/2015
10,000


 
Disposition at $72.34 per share.


723,400


11/10/2015
10,000


 
Derivative/Non-derivative trans. at $15.95 per share.


159,500


11/04/2015
1,500


 
Gift at $0 per share.


0


10/13/2015
4,346


 
Disposition at $60.72 per share.


263,890


10/13/2015
5,949


 
Disposition at $60.2 per share.


358,130


10/13/2015
9,705


 
Disposition at $59.09 per share.


573,469


10/13/2015
10,000


 
Derivative/Non-derivative trans. at $11.74 per share.


117,400


10/13/2015
10,000


 
Derivative/Non-derivative trans. at $14.38 per share.


143,800


10/05/2015
2,356


 
Derivative/Non-derivative trans. at $59.77 per share.


140,819


10/05/2015
5,000


 
Award at $0 per share.


0


09/15/2015
9,200


 
Disposition at $71.39 per share.


656,788


09/15/2015
10,800


 
Disposition at $70.85 per share.


765,180


09/15/2015
10,000


 
Derivative/Non-derivative trans. at $14.38 per share.


143,800


09/15/2015
10,000


 
Derivative/Non-derivative trans. at $11.74 per share.


117,400


08/11/2015
6,926


 
Disposition at $68.13 per share.


471,869


08/11/2015
3,074


 
Disposition at $67.63 per share.


207,895


08/11/2015
10,000


 
Derivative/Non-derivative trans. at $14.38 per share.


143,800


07/14/2015
8,485


 
Disposition at $66.37 per share.


563,150


07/14/2015
11,515


 
Disposition at $65.37 per share.


752,736


07/14/2015
10,000


 
Derivative/Non-derivative trans. at $11.74 per share.


117,400


07/14/2015
10,000


 
Derivative/Non-derivative trans. at $14.38 per share.


143,800


06/16/2015
10,000


 
Disposition at $58.63 per share.


586,300


06/16/2015
10,000


 
Derivative/Non-derivative trans. at $11.74 per share.


117,400


05/28/2015
1,178


 
Derivative/Non-derivative trans. at $59.92 per share.


70,586


05/28/2015
2,500


 
Derivative/Non-derivative trans. at $0 per share.


0


05/21/2015
1,767


 
Derivative/Non-derivative trans. at $61.8 per share.


109,201


05/21/2015
3,750


 
Derivative/Non-derivative trans. at $0 per share.


0


05/20/2015
1,767


 
Derivative/Non-derivative trans. at $62.1 per share.


109,731


05/20/2015
3,750


 
Derivative/Non-derivative trans. at $0 per share.


0


05/12/2015
10,000


 
Disposition at $59.34 per share.


593,400


05/12/2015
10,000


 
Derivative/Non-derivative trans. at $11.74 per share.


117,400


04/15/2015
10,000


 
Disposition at $62.42 per share.


624,200


04/15/2015
10,000


 
Derivative/Non-derivative trans. at $9.21 per share.


92,100


03/10/2015
1,400


 
Disposition at $66.87 per share.


93,618


03/10/2015
8,600


 
Disposition at $66.15 per share.


568,890


03/10/2015
10,000


 
Derivative/Non-derivative trans. at $9.21 per share.


92,100


03/03/2015
1,325


 
Derivative/Non-derivative trans. at $72.8 per share.


96,460


03/03/2015
2,812


 
Derivative/Non-derivative trans. at $0 per share.


0


02/03/2015
1,000


 
Disposition at $72.49 per share.


72,490


02/03/2015
2,200


 
Disposition at $71.43 per share.


157,146


02/03/2015
6,800


 
Disposition at $70.39 per share.


478,652


02/03/2015
10,000


 
Derivative/Non-derivative trans. at $9.21 per share.


92,100


01/15/2015
500


 
Disposition at $68.12 per share.


34,060


01/15/2015
3,800


 
Disposition at $67.17 per share.


255,246


01/15/2015
5,700


 
Disposition at $66.55 per share.


379,335


01/15/2015
10,000


 
Derivative/Non-derivative trans. at $9.21 per share.


92,100


12/10/2014
700


 
Disposition at $56.65 per share.


39,655


12/10/2014
18,170


 
Disposition at $56.04 per share.


1,018,247


12/10/2014
10,000


 
Derivative/Non-derivative trans. at $9.21 per share.


92,100


12/10/2014
8,870


 
Derivative/Non-derivative trans. at $14.9 per share.


132,163


12/03/2014
8,000


 
Disposition at $55.72 per share.


445,760


12/03/2014
8,000


 
Derivative/Non-derivative trans. at $14.9 per share.


119,200


11/19/2014
8,000


 
Disposition at $53.86 per share.


430,880


11/19/2014
8,000


 
Derivative/Non-derivative trans. at $14.9 per share.


119,200


11/07/2014
763


 
Disposition at $49.98 per share.


38,135


11/07/2014
12,540


 
Disposition at $49.98 per share.


626,750


11/07/2014
8,000


 
Derivative/Non-derivative trans. at $14.9 per share.


119,200


11/07/2014
5,303


 
Derivative/Non-derivative trans. at $8.55 per share.


45,340


10/31/2014
4,810


 
Derivative/Non-derivative trans. at $20.79 per share.


99,999


10/31/2014
1,978


 
Derivative/Non-derivative trans. at $50.55 per share.


99,988


10/31/2014
8,517


 
Derivative/Non-derivative trans. at $11.74 per share.


99,989


10/31/2014
1,978


 
Derivative/Non-derivative trans. at $50.55 per share.


99,988


10/31/2014
8,136


 
Derivative/Non-derivative trans. at $12.29 per share.


99,991


10/31/2014
1,978


 
Derivative/Non-derivative trans. at $50.55 per share.


99,988


10/31/2014
6,269


 
Derivative/Non-derivative trans. at $15.95 per share.


99,990


10/31/2014
1,978


 
Derivative/Non-derivative trans. at $50.55 per share.


99,988


10/31/2014
1,978


 
Derivative/Non-derivative trans. at $50.55 per share.


99,988


10/31/2014
11,697


 
Derivative/Non-derivative trans. at $8.55 per share.


100,009


10/31/2014
1,978


 
Derivative/Non-derivative trans. at $50.55 per share.


99,988


10/31/2014
5,376


 
Derivative/Non-derivative trans. at $18.6 per share.


99,993


10/08/2014
16,000


 
Disposition at $41 per share.


656,000


10/08/2014
8,000


 
Derivative/Non-derivative trans. at $14.9 per share.


119,200


10/08/2014
8,000


 
Derivative/Non-derivative trans. at $8.55 per share.


68,400


09/24/2014
16,000


 
Disposition at $45.29 per share.


724,640


09/24/2014
8,000


 
Derivative/Non-derivative trans. at $14.9 per share.


119,200


09/24/2014
8,000


 
Derivative/Non-derivative trans. at $8.55 per share.


68,400


09/10/2014
16,000


 
Disposition at $43.18 per share.


690,880


09/10/2014
8,000


 
Derivative/Non-derivative trans. at $14.9 per share.


119,200


09/10/2014
8,000


 
Derivative/Non-derivative trans. at $8.55 per share.


68,400


08/27/2014
16,000


 
Disposition at $45.08 per share.


721,280


08/27/2014
8,000


 
Derivative/Non-derivative trans. at $14.9 per share.


119,200


08/27/2014
8,000


 
Derivative/Non-derivative trans. at $8.55 per share.


68,400


08/13/2014
15,000


 
Disposition at $41.37 per share.


620,550


08/13/2014
8,000


 
Derivative/Non-derivative trans. at $8.55 per share.


68,400


08/13/2014
7,000


 
Derivative/Non-derivative trans. at $14.9 per share.


104,300


07/16/2014
8,000


 
Disposition at $46.5 per share.


372,000


07/16/2014
8,000


 
Derivative/Non-derivative trans. at $8.55 per share.


68,400


07/09/2014
1,400


 
Disposition at $48.19 per share.


67,466


07/09/2014
5,600


 
Disposition at $47.22 per share.


264,432


07/09/2014
7,000


 
Derivative/Non-derivative trans. at $14.9 per share.


104,300


06/25/2014
7,000


 
Disposition at $50.22 per share.


351,540


06/25/2014
7,000


 
Derivative/Non-derivative trans. at $14.9 per share.


104,300


06/11/2014
7,000


 
Disposition at $47.72 per share.


334,040


06/11/2014
7,000


 
Derivative/Non-derivative trans. at $14.9 per share.


104,300


05/28/2014
1,179


 
Derivative/Non-derivative trans. at $45.74 per share.


53,928


05/28/2014
2,500


 
Derivative/Non-derivative trans. at $0 per share.


0


05/21/2014
1,769


 
Derivative/Non-derivative trans. at $44.48 per share.


78,686


05/21/2014
3,750


 
Derivative/Non-derivative trans. at $0 per share.


0


05/21/2014
7,000


 
Disposition at $44.3 per share.


310,100


05/21/2014
7,000


 
Derivative/Non-derivative trans. at $14.9 per share.


104,300


05/20/2014
1,769


 
Derivative/Non-derivative trans. at $43.98 per share.


77,801


05/20/2014
3,750


 
Derivative/Non-derivative trans. at $0 per share.


0


05/17/2014
2,052


 
Derivative/Non-derivative trans. at $43.59 per share.


89,447


05/17/2014
4,350


 
Derivative/Non-derivative trans. at $0 per share.


0


05/07/2014
1,000


 
Disposition at $46.78 per share.


46,780


05/07/2014
6,000


 
Disposition at $45.6 per share.


273,600


05/07/2014
5,130


 
Derivative/Non-derivative trans. at $14.9 per share.


76,437


05/07/2014
1,870


 
Derivative/Non-derivative trans. at $12.3 per share.


23,001


04/09/2014
7,000


 
Disposition at $42.91 per share.


300,370


04/09/2014
7,000


 
Derivative/Non-derivative trans. at $12.3 per share.


86,100


03/19/2014
7,000


 
Disposition at $46.84 per share.


327,880


03/19/2014
7,000


 
Derivative/Non-derivative trans. at $12.3 per share.


86,100


03/05/2014
7,000


 
Disposition at $47.78 per share.


334,460


03/05/2014
7,000


 
Derivative/Non-derivative trans. at $12.3 per share.


86,100


01/16/2014
7,000


 
Disposition at $47.4 per share.


331,800


01/16/2014
7,000


 
Derivative/Non-derivative trans. at $12.3 per share.


86,100


12/20/2013
8,130


 
Derivative/Non-derivative trans. at $12.3 per share.


99,999


12/17/2013
30,437


 
Disposition at $39 per share.


1,187,043


12/17/2013
25,437


 
Derivative/Non-derivative trans. at $18.6 per share.


473,128


12/16/2013
5,737


 
Disposition at $39.73 per share.


227,932


12/16/2013
24,700


 
Disposition at $38.92 per share.


961,324


12/16/2013
25,437


 
Derivative/Non-derivative trans. at $18.6 per share.


473,128


12/11/2013
7,000


 
Disposition at $39.42 per share.


275,940


12/11/2013
7,000


 
Derivative/Non-derivative trans. at $12.3 per share.


86,100


11/21/2013
4,988


 
Disposition at $37.89 per share.


188,996


11/18/2013
2,950


 
Derivative/Non-derivative trans. at $36.89 per share.


108,826


11/18/2013
6,250


 
Derivative/Non-derivative trans. at $0 per share.


0


11/14/2013
13,487


 
Disposition at $37.3 per share.


503,066


11/14/2013
8,499


 
Derivative/Non-derivative trans. at $12.16 per share.


103,347


10/08/2013
1


 
Derivative/Non-derivative trans. at $12.16 per share.


12


10/08/2013
875


 
Derivative/Non-derivative trans. at $14.57 per share.


12,748


09/25/2013
7,500


 
Disposition at $33.73 per share.


252,975


09/25/2013
7,500


 
Derivative/Non-derivative trans. at $12.16 per share.


91,200


09/19/2013
15,000


 
Disposition at $35.07 per share.


526,050


09/19/2013
15,000


 
Derivative/Non-derivative trans. at $12.16 per share.


182,400


08/14/2013
15,000


 
Disposition at $33.21 per share.


498,150


08/14/2013
15,000


 
Derivative/Non-derivative trans. at $12.16 per share.


182,400


08/07/2013
7,500


 
Disposition at $34.07 per share.


255,525


08/07/2013
7,500


 
Derivative/Non-derivative trans. at $12.16 per share.


91,200


07/17/2013
15,000


 
Disposition at $29.93 per share.


448,950


07/17/2013
15,000


 
Derivative/Non-derivative trans. at $12.16 per share.


182,400


07/11/2013
15,000


 
Disposition at $30.04 per share.


450,600


07/11/2013
15,000


 
Derivative/Non-derivative trans. at $12.16 per share.


182,400


06/19/2013
15,275


 
Disposition at $29.24 per share.


446,641


06/19/2013
15,275


 
Derivative/Non-derivative trans. at $14.57 per share.


222,556


06/12/2013
8,350


 
Disposition at $30.5 per share.


254,675


06/12/2013
8,350


 
Derivative/Non-derivative trans. at $14.57 per share.


121,659


05/26/2013
1,003


 
Derivative/Non-derivative trans. at $32.84 per share.


32,939


05/26/2013
2,125


 
Derivative/Non-derivative trans. at $0 per share.


0


05/21/2013
1,223


 
Derivative/Non-derivative trans. at $31.98 per share.


39,112


05/21/2013
3,750


 
Derivative/Non-derivative trans. at $0 per share.


0


05/20/2013
1,223


 
Derivative/Non-derivative trans. at $31.04 per share.


37,962


05/20/2013
3,750


 
Derivative/Non-derivative trans. at $0 per share.


0


05/17/2013
1,419


 
Derivative/Non-derivative trans. at $31.69 per share.


44,969


05/17/2013
4,350


 
Derivative/Non-derivative trans. at $0 per share.


0


03/14/2013
15,750


 
Disposition at $22.79 per share.


358,943


03/14/2013
7,000


 
Derivative/Non-derivative trans. at $14.57 per share.


101,990


03/14/2013
8,750


 
Derivative/Non-derivative trans. at $9.97 per share.


87,237


02/14/2013
8,750


 
Disposition at $21.34 per share.


186,725


02/14/2013
8,750


 
Derivative/Non-derivative trans. at $9.97 per share.


87,237


01/16/2013
8,750


 
Disposition at $22.22 per share.


194,425


01/16/2013
8,750


 
Derivative/Non-derivative trans. at $9.97 per share.


87,237


12/31/2012
3,752


 
Disposition at $18.33 per share.


68,775


12/28/2012
3,752


 
Disposition at $18.76 per share.


70,388


12/05/2012
3,002


 
Disposition at $19.64 per share.


58,960


12/05/2012
3,002


 
Derivative/Non-derivative trans. at $7.36 per share.


22,094


11/28/2012
5,364


 
Disposition at $19.28 per share.


103,418


11/28/2012
5,364


 
Derivative/Non-derivative trans. at $7.36 per share.


39,479


11/21/2012
5,364


 
Disposition at $19.84 per share.


106,422


11/21/2012
5,364


 
Derivative/Non-derivative trans. at $7.36 per share.


39,479


11/18/2012
2,607


 
Derivative/Non-derivative trans. at $19.49 per share.


50,811


11/18/2012
6,250


 
Derivative/Non-derivative trans. at $0 per share.


0


11/14/2012
5,364


 
Disposition at $20.15 per share.


108,085


11/14/2012
5,364


 
Derivative/Non-derivative trans. at $7.36 per share.


39,479


11/13/2012
3,180


 
Derivative/Non-derivative trans. at $20.19 per share.


64,205


11/13/2012
8,726


 
Derivative/Non-derivative trans. at $7.36 per share.


64,223


11/13/2012
4,320


 
Derivative/Non-derivative trans. at $20.19 per share.


87,221


11/13/2012
8,750


 
Derivative/Non-derivative trans. at $9.97 per share.


87,237


10/17/2012
5,364


 
Disposition at $19.83 per share.


106,369


10/17/2012
5,364


 
Derivative/Non-derivative trans. at $7.36 per share.


39,479


10/10/2012
5,364


 
Disposition at $19.56 per share.


104,920


10/10/2012
5,364


 
Derivative/Non-derivative trans. at $7.36 per share.


39,479


10/03/2012
5,363


 
Disposition at $20.64 per share.


110,693


10/03/2012
5,363


 
Derivative/Non-derivative trans. at $7.36 per share.


39,471


09/26/2012
5,363


 
Disposition at $20.65 per share.


110,746


09/26/2012
5,363


 
Derivative/Non-derivative trans. at $7.36 per share.


39,471


08/15/2012
5,363


 
Disposition at $17.73 per share.


95,086


08/15/2012
5,363


 
Derivative/Non-derivative trans. at $7.36 per share.


39,471


08/08/2012
5,363


 
Disposition at $17.89 per share.


95,945


08/08/2012
5,363


 
Derivative/Non-derivative trans. at $7.36 per share.


39,471





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Richard F. Pops 
Chairman & Chief Executive Officer




Mr. Shane M. Cooke 
President




Mr. James M. Frates 
Chief Financial Officer & Senior Vice President




Dr. Craig  Hopkinson 
Chief Medical Officer




Dr. Elliot W. Ehrich 
Executive Vice President-Research &Development




Mr. Blair C. Jackson 
Vice President-Business Development




Mr. Michael J. Landine 
Senior Vice President-Corporate Development




Ms. Kathryn L. Biberstein 
Secretary, Chief Compliance, Legal Officer & SVP




Dr. Nancy L. Snyderman 
Director




Mr. Iain Michael Brown 
Chief Accounting Officer & Senior VP-Finance




Ms. Eva  Stroynowski 
Investor Relations Contact




Ms. Rebecca J. Peterson 
Senior Vice President-Corporate Communications




Ms. Madeline D. Coffin 
Vice President-Human Resources




Mr. David Jose Gaffin 
Chief Legal Officer & Senior Vice President




Mr. Paul J. Mitchell 
Lead Independent Director




Mr. Robert A. Breyer 
Independent Director




Dr. Floyd E. Bloom 
Independent Director




Mr. David Westbrook Anstice 
Independent Director




Ms. Nancy J. Wysenski 
Independent Director




Dr. Wendy L. Dixon 
Independent Director
















Log In




3:09 AM EDT
July 23, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
5:12pTrump says he has ‘complete power to pardon’
5:08pLawmakers reach deal on Russia sanctions bill: reports
5:00pAlphabet earnings: A $2.74 billion hit for Google, potential YouTube results for investors
3:30pYou can date someone who looks just like Donald Trump with this new online service 
3:29pWant to buy happiness? Splurge on these 5 things
3:28pThis is what people really buy when they emotionally overspend (hint: it’s not designer clothes)
2:40pJohn McCain is a war hero — but think twice before saying he’s ‘battling’ cancer 
2:38pThe dark side of cruises
2:37pI want to buy my brothers out of our family home — but they want me to pay (future) sales fees
2:35pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
2:34pNot even free money can make some people go to the gym 
2:34pHow real-estate TV shows determine what buyers look for in a house
2:34pWhat Eleanor Roosevelt and Helen Gurley Brown ate — and what we can learn from it 
2:33pNote to parents: This social network was rated the worst for teenage cyberbullying
2:33pIf, like Sean Spicer, you suddenly quit your job — what should you do next?
2:32pThis is the deadliest time of your life to put on weight
2:32p5 unfortunate reasons why millennials can’t have nice things (or save any money)
2:26pU.S. giving takeover bids by Chinese firms much tougher look
1:13pJared Kushner discloses dozens of additional assets in revised filing
12:51pBitcoin surges as miners avert split for now
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,580.07

-31.71
-0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,387.75

-2.25
-0.04%





s&p 500

/quotes/zigman/3870025/realtime
2,472.54

-0.91
-0.04%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15






















































   James Frates | Alkermes , Inc. | ZoomInfo.comJames M. Frates, Sr. VP, CFO, Treasurer, Alkermes Inc.














A publisher of Business Information since 1983   
  





 


   

Search Business Search Executive 
  Advanced Search 




  

Sign In  |  Hints 









Profile of James Frates 





 


James Frates

 

Sr. VP, CFO, Treasurer - Alkermes Inc.

 


James Frates Email :
Please login 

 

Company Name : 
Alkermes Inc. 

 

Company Website : 
www.alkermes.com 

 

Company Address : 
88 Sidney St., Cambridge, MA,United States, 


 


James Frates Profile :
Sr. VP, CFO, Treasurer - Alkermes Inc. 

 


James Frates Biography :


Jim Frates directs the Finance and Corporate Communications departments at Alkermes. During his tenure, Alkermes has raised substantial public capital and acquired the pulmonary drug delivery company, Advanced Inhalation Research, Inc. (AIR�). Jim was previously a Vice President in charge of the East Coast Life Sciences Practice at Robertson Stephens & Company, Inc. He has also worked in health care investment banking at Morgan Stanley & Company, Inc. and spent a year teaching secondary school at the Royal Shrewsbury School in the U.K., as the Harvard College Fellow. Jim currently serves as Audit Committee Chairman on the Board of Directors of GPC Biotech of Germany and serves as a national chairperson of the Association of Bioscience Financial Officers. Jim received a B.A. in Government from Harvard College and an M.B.A. from Harvard Graduate School of Business Administration 

 


James Frates Colleagues :





Name 
Title 
Email 


Robert Breyer 
Dir. 
Please login 


Michael Wall 
Board Dir. 
Please login 


Floyd Bloom 
Dir. 
Please login 


Alexander Rich 
Dir. 
Please login 


Richard Pops 
Chmn. 
Please login 













            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory    





 

� 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.





JAMES M. FRATES - ALKERMES DEVELOPMENT CORPORATION II - Business Profiles





















Business Profile

Document Delivery
API
About





 

 

 Companies
 Officers

 








Home  /  
Massachusetts
  /  
ALKERMES DEVELOPMENT CORPORATION II
  /  
JAMES M. FRATES





Account  


Login


Sign Up






Saved

0




Cart

0













JAMES M. FRATES

 Massachusetts
 MA-043145041
 




JAMES M. FRATES is the Registered Agent and Treasurer of ALKERMES DEVELOPMENT CORPORATION II, registered in Massachusetts.




Save Profile  
 







DETAILS


Name: JAMES M. FRATES
Office Held: Registered Agent
Office Held: Treasurer




LOCATIONS


A Address

133 LOWELL ST. , WELLESLEY, MA 02481, USA



















Home
Document Delivery
API
About

© 2017, Business Profiles Inc.
Business Profile





USA
Europe
Asia & Pacific
Americas





Alabama


Alaska


Arizona


Arkansas


California




Colorado


Connecticut


Delaware


District of Columbia


Florida




Georgia


Hawaii


Idaho


Illinois


Indiana




Iowa


Kansas


Kentucky


Louisiana


Maine




Maryland


Massachusetts


Michigan


Minnesota


Mississippi




Missouri


Nevada


New Hampshire


New Jersey


New York




North Carolina


North Dakota


Ohio


Oklahoma


Oregon




Pennsylvania


Puerto Rico


South Carolina


South Dakota


Tennessee




Texas


Utah


Virginia


Washington


Wyoming






Croatia


Denmark


Estonia




Finland


France




Germany


Gibraltar




Ireland


Isle of Man




Luxembourg


Netherlands




Norway


Poland




Slovenia


Spain




Sweden


Switzerland




Turkey


United Kingdom






Australia




Hong Kong




India




New Zealand




Singapore




Thailand












Canada




Colombia




Dominican Republic




Jamaica




Jersey




Mexico




Nova Scotia




Panama




Quebec












403 - Forbidden: Access is denied.



Server Error


403 - Forbidden: Access is denied.
You do not have permission to view this directory or page using the credentials that you supplied.




﻿

Richard Pops, Chairman and CEO of Alkermes Biotech Company | Alkermes




























Home
Contact Us
Site Map














About Us

About Us


About Alkermes
Our Company
Message From the CEO
Locations


Leadership
Management Team
Board of Directors


Collaborations
Strategic Partners





Products

Products


Products
Products Overview


United States
ARISTADA®
VIVITROL®
U.S. Products Using Alkermes Technologies
Wholesaler and Purchasing Information


European Union
EU Products Using Alkermes Technologies





Research & Development

Research & Development


Research & Development
R&D Overview
Our R&D Approach
Pipeline
Technology Platforms
Manufacturing


Other Information
Clinical Trials
Expanded Access





Responsibility

Responsibility


Responsibility
Alkermes Corporate Giving
Investigator Initiated Trials
Educational Grants
Patient Engagement Support
ALKERMES Inspiration Grants™





Investors

Investors


Investors
Corporate Overview
Press Releases
Investor Events
Stock Information
SEC Filings
Annual Reports


Financials
Snapshot
Trading Statistics


Other Information
Email Alerts





News & Events

News & Events


News & Events
Press Releases
Media Kit





Careers

Careers


Careers
Working Together
Our Core Values
Total Rewards
Meet Our Employees
Recruiting Agencies
Equal Opportunity Employer


Job Opportunities
Jobs Overview
Field Sales Roles
All Available Roles












About Us







Home
About Us
Management Team












About Alkermes

Our Company
Message From the CEO
Locations

Leadership

Management Team
Board of Directors

Collaborations

Strategic Partners





Management Team










Richard Pops serves as Chairman and Chief Executive Officer of Alkermes. He joined Alkermes as CEO in 1991. Under his leadership, Alkermes has grown from a privately held company with 25 employees to an international, publicly traded biopharmaceutical company with more than 1,900 employees. Alkermes has a diversified commercial product portfolio and a substantial clinical pipeline of central nervous system (CNS) product candidates. Mr. Pops currently serves on the Board of Directors of Neurocrine Biosciences, Acceleron Pharma, Epizyme, the Biotechnology Industry Organization (BIO), the Pharmaceutical Research and Manufacturers of America (PhRMA) and the National Health Council.









Shane Cooke oversees corporate finance, commercial, business development, corporate planning, quality and manufacturing operations. Mr. Cooke joined Alkermes as President upon completion of the merger between Elan Drug Technologies (EDT) and Alkermes, Inc. in September 2011. Previously, Mr. Cooke was Head of EDT and Executive Vice President of Elan from 2007 through the merger in 2011 and concurrently served as Chief Financial Officer of Elan Corporation from 2001 to May 2011. Mr. Cooke was appointed Director of Elan in May 2005. Prior to joining Elan, Mr. Cooke was Chief Executive of Pembroke Capital Limited, an aviation leasing company of which he was a founder. Mr. Cooke also previously held a number of senior positions in finance in the banking and aviation industries.  Mr. Cooke currently serves on the Board of Directors of Endo International plc and on the Board of Directors of Prothena Biosciences and Prothena Therapeutics, both subsidiaries of Prothena Corporation plc. Mr. Cooke is a chartered accountant and a graduate of University College Dublin, Ireland.









Kathy Biberstein oversees compliance, intellectual property, legal, policy, information technology, human resources and operations at the Waltham site. She also has responsibility for enterprise risk management. Ms. Biberstein held several senior legal positions prior to joining Alkermes in 2003, including General Counsel and member of the Executive Committee at Serono in Geneva, Switzerland from 1993 to 2000, where she built a worldwide legal department. Just prior to joining Alkermes, Ms. Biberstein was Of Counsel at Crowell & Moring LLC, and earlier in her career, Ms. Biberstein was a member of the Executive Board of the World Economic Forum. Ms. Biberstein received a Bachelor of Science degree from Kettering University and a Juris Doctor from the University of Michigan Law School.









Iain Brown is responsible for Alkermes’ accounting and financial reporting systems, as well as its tax, treasury, financial planning and analysis, and insurance functions. Mr. Brown has more than 20 years of experience in the biopharmaceutical industry. He joined Alkermes in 2003, prior to which he managed EMD Serono’s North America financial operations. Mr. Brown received a Bachelor of Science in Business Studies from the University of Bradford, England and is a Chartered Accountant.









Madeline Coffin leads Alkermes’ human resources team, with responsibility for global compensation and benefits, talent acquisition, employee engagement and growth and organization development. Ms. Coffin has held a number of senior human resource positions at companies including Analog Devices, Sun Microsystems, Wang Software and Bay Networks. Prior to joining Alkermes, she founded her own company, which focused on the strategic human resource needs of growing companies for clients in a broad range of industries. Ms. Coffin holds a Bachelor of Arts degree from Penn State University and a Master of Industrial and Labor Relations from Cornell University.









Elliot Ehrich leads the discovery, delivery science, research and development, project management and medical affairs functions at Alkermes. Prior to joining Alkermes in 2000, Dr. Ehrich spent seven years at Merck & Co., overseeing the successful clinical development and registration of novel pharmaceuticals. Dr. Ehrich is a Fellow of the American College of Rheumatology and has had numerous publications in peer-reviewed journals. He also serves on the Scientific Advisory Boards of Aileron Therapeutics and Heptares Therapeutics, both privately held biopharmaceutical companies, as well as a Strategic Advisor at Verge Genomics. Dr. Ehrich was a Phi Beta Kappa graduate of Princeton University where he received a Bachelor of Arts degree in biochemistry. He worked as a research associate at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany and later earned his medical degree from Columbia University, College of Physicians and Surgeons. At Stanford University, Dr. Ehrich completed a residency in internal medicine and a clinical fellowship in the Department of Immunology and Rheumatology. He was subsequently a postdoctoral research fellow at the Howard Hughes Medical Institute at Stanford University School of Medicine, in the Department of Microbiology and Immunology.









Jim Frates serves as Chief Financial Officer of Alkermes. Prior to joining Alkermes in 1998, Mr. Frates was a Vice President in charge of the East Coast Life Sciences Practice at Robertson Stephens & Company. He also worked in healthcare investment banking at Morgan Stanley & Company and spent a year teaching secondary school at the Royal Shrewsbury School in the U.K., as the Harvard College Fellow. Mr. Frates served on the Board of Directors of GPC Biotech AG from June 2004 to June 2009 and was a national director of the Association of Bioscience Financial Officers.  Mr. Frates serves on the Board of Directors of SAGE Therapeutics and as a Trustee of the Roxbury Latin School. Mr. Frates received a Bachelor of Arts degree in government from Harvard College and a Master of Business Administration from Harvard Graduate School of Business Administration.









David Gaffin serves as Alkermes’ in-house Chief Legal Officer, managing the operations of the legal department. Mr. Gaffin was most recently the U.S. General Counsel of Alkermes. Prior to joining the company in 2005, Mr. Gaffin held the role of Assistant General Counsel at Biogen Inc., where he provided legal counsel on product-related matters and negotiated collaboration and licensing transactions. Mr. Gaffin received a Bachelor of Arts degree from Harvard College, a Master of Business Administration from J.L. Kellogg Graduate School of Management and a Juris Doctor from Northwestern University School of Law.









Georgianna Harris leads the regulatory affairs department at Alkermes. In this role, Dr. Harris provides regulatory strategy and guidance for development candidates and commercial products. Prior to joining Alkermes, Dr. Harris spent 25 years at Merck, in positions of increasing responsibility spanning laboratory research and regulatory affairs. During her tenure with Merck’s regulatory affairs organization, Dr. Harris oversaw global development, registration and post-registration activities for multiple small-molecule and biologic medicines for obesity, bone, oncology, diabetes and women’s health indications. Dr. Harris received a Bachelor of Science degree from Boston College and a Ph.D. in biochemistry from the University of Wisconsin. She was subsequently a postdoctoral research fellow at the Massachusetts Institute of Technology, in the Department of Chemistry.









Craig Hopkinson, M.D., is responsible for evolving and executing the clinical development programs for the company’s pipeline of drug candidates. Dr. Hopkinson has more than 20 years of experience building and leading clinical development organizations and medical affairs groups in the biopharmaceutical industry. He has led multidisciplinary development teams in multiple therapeutic areas, including neuroscience, oncology, gastroenterology, infectious diseases, cardiovascular conditions, inflammation, genetic diseases, hematology and neurodegenerative diseases, and has extensive knowledge of clinical study design and the regulatory landscape. Most recently, Dr. Hopkinson held the position of Senior Vice President and Head of Global Medical Affairs for Vertex Pharmaceuticals. Prior to this role, Dr. Hopkinson held various executive management positions at Eisai Pharmaceuticals, including President of Eisai Value Maximization Systems, President and Chief Medical Officer of the Frontier Product Creation Unit, and Vice President of Medical Affairs, Oncology. In addition, Dr. Hopkinson served in leadership positions at Elan Pharmaceuticals, Actelion Pharmaceuticals and Pfizer. Dr. Hopkinson completed his Bachelor of Medicine and Bachelor of Surgery at the University of the Orange Free State in South Africa.









Blair Jackson leads business development at Alkermes, encompassing licensing efforts, new product evaluation and alliance management. Since joining Alkermes in 1999, Mr. Jackson has served in various roles within the company in both a scientific and corporate capacity. Mr. Jackson serves on the Board of Directors of Reset Therapeutics, Inc. Mr. Jackson received a Bachelor of Arts degree in biochemistry from the University of Calgary, a Bachelor of Arts in chemical engineering and a Master of Business Administration from the University of Alberta, and a Master of Science in chemical engineering practice from the Massachusetts Institute of Technology.









Mike Landine oversees Alkermes’ corporate development activities. Prior to leading corporate development, Mr. Landine served as Chief Financial Officer and Treasurer of Alkermes from March 1988 until June 1998. Mr. Landine is a member of the Board of Directors of Kopin Corporation, a publicly traded manufacturer of components for electronic products. He also previously served on the Board of Directors of GTC Biotherapeutics, a biotechnology company, from 2005 to 2010. Mr. Landine received a Bachelor of Science degree in accounting from Bentley University and is a Certified Public Accountant.









Mark Namchuk leads research, pharmaceutical development, process development and nonclinical development of the company’s early-stage product pipeline at Alkermes. Prior to joining Alkermes in 2015, Dr. Namchuk served as Senior Vice President and Interim Global Head of Research for Vertex Pharmaceuticals, leading a group of more than 450 researchers in the discovery of transformational medicines in the areas of infectious disease, oncology, inflammatory diseases, neurology and cystic fibrosis. In addition, Dr. Namchuk developed the high throughput enzymology paradigm in support of the Vertex Chemogenomics effort and co-chaired the committee responsible for new-target selection and prosecution for the company. Earlier in his career, he served as the head of the biochemistry group at Cubist Pharmaceuticals. Dr. Namchuk obtained his doctorate in bioorganic chemistry from the University of British Columbia and completed a post-doctoral fellowship at the University of California, San Francisco.









Peter Norman leads the U.S. Government Affairs and Policy function for the company, which includes federal and state initiatives as well as programs with professional and patient organizations. Prior to joining Alkermes in 2013, Mr. Norman was the head of the Washington, D.C. office for Eisai, Inc. In addition, he’s held senior positions for Amylin Pharmaceuticals, Inc., Millennium Pharmaceuticals, Inc., Novo Nordisk and the Biotechnology Industry Organization (BIO). Mr. Norman worked on public policy and regulatory strategies not only for Alzheimer’s disease, obesity and diabetes pharmaceutical products, but also healthcare reform and reimbursement issues. He received a Bachelor of Arts degree from Adrian College and a Juris Doctor from the University of Toledo College of Law.









Declan O’Connor is responsible for Alkermes’ manufacturing operations at the Athlone, Ireland and Wilmington, Ohio sites as well as its commercial and clinical supply chain functions. Mr. O’Connor is responsible for the strategic development of operations activities and site infrastructure development. He joined Alkermes as Vice President and General Manager in Athlone upon completion of the merger between Elan Drug Technologies (EDT) and Alkermes, Inc. in September 2011. In this role, he was responsible for the company’s FDA/EMA licensed multi-product development, manufacturing and packaging operations in Ireland. Mr. O’Connor held a number of senior operations positions for Elan including Vice President of Finance, Head of Global Supply Chain and Head of Finance U.S. Operations. Mr. O’Connor is a chartered accountant and a graduate of University College Dublin, Ireland.









Phil Shanahan is responsible for quality control, quality assurance and compliance at the Athlone, Ireland and Wilmington, Ohio sites, and the quality assurance function at the Waltham site. Dr. Shanahan joined Alkermes as Vice President, Quality Operations upon completion of the merger between Elan Drug Technologies (EDT) and Alkermes, Inc. in September 2011. Dr. Shanahan has more than 15 years of experience in quality operations. Prior to joining Elan, he served at Servier and Janssen Global Services, LLC. Dr. Shanahan obtained his doctorate in analytical biotechnology and his Bachelor of Science in chemistry from University College Cork. He holds a diploma in pharmaceutical manufacturing technology and is a certified Qualified Person (QP) for the release of product to the European Union.









Mark Stejbach serves as Chief Commercial Officer at Alkermes and is responsible for all aspects of Alkermes’ commercial functions, including sales, marketing, managed care and trade channels, commercial analytics, public policy and the development of commercial strategy for the company’s proprietary pipeline. Mr. Stejbach has more than 25 years of experience in biotech and pharmaceutical marketing, sales, managed care, and finance. Prior to joining Alkermes, Mr. Stejbach served at Tengion, Inc. from 2008 to 2012, most recently as Chief Commercial Officer. He previously held senior positions at Merck & Co. and Biogen Idec Inc. He currently serves on the Board of Directors of Flexion Therapeutics. Mr. Stejbach received his MBA from The Wharton School, University of Pennsylvania and a Bachelor of Science in mathematics from Virginia Tech.





Richard F. Pops



ShaneCooke



Kathryn L. Biberstein



IainBrown



Madeline D. Coffin



Elliot W. Ehrich, M.D.



James M. Frates



David J.Gaffin



Georgianna Harris, Ph.D.



Craig Hopkinson, M.D.



Blair C. Jackson



Michael J. Landine



Mark Namchuk, Ph.D.



PeterNorman



Declan O’Connor



Phil Shanahan, Ph.D.



Mark P. Stejbach










You are now leaving Alkermes.com.






About Us


Our Company


Message From the CEO


Locations


Management Team


Board of Directors


Strategic Partners


Products


Products Overview


ARISTADA®


VIVITROL®


U.S. Products Using Alkermes Technologies


EU Products Using Alkermes Technologies


Wholesaler and Purchasing Information




Research & Development


R&D Overview


Our R&D Approach


Pipeline


Technology Platforms


Manufacturing


Clinical Trials


Expanded Access


Responsibility


Alkermes Corporate Giving


Investigator Initiated Trials


Educational Grants


Patient Engagement Support


ALKERMES Inspiration Grants™




Investors


Corporate Overview


Press Releases


Investor Events


Stock Information


SEC Filings


Annual Reports


Snapshot


Trading Statistics


Email Alerts




News & Events


Press Releases


Media Kit


Careers


Working Together


Our Core Values


Total Rewards


Meet Our Employees


Recruiting Agencies


Equal Opportunity Employer


Jobs Overview


Field Sales Roles


All Available Roles








©2017 Alkermes. All Rights Reserved
Terms of Use
Privacy Policy








James Frates: Veromi's People Search and Business Directory
























People SearchBackground CheckCriminal CheckPeople DirectoryBusiness DirectoryAll ProductsWhy Veromi



The Trusted Information Source


Login

Search

Help


















Find Person: James Frates.


Veromi People Index: NOW WITH BUSINESS DATA. The most comprehensive People Database in the World.









Start your search now!




Name
Address
Phone







First Name:



Middle Initial: 



Last Name: 






Approx. Age:





City:




State:


Select state...
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
Washington DC
West Virginia
Wisconsin
Wyoming










Address:



Zip:






City:




State:


Select a state...
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
Washington DC
West Virginia
Wisconsin
Wyoming















Phone Number:

























Search Results for 
 James Frates



We found 29 people that match 
James Frates 
.





Person


Ageapprox


Has lived in


Possible Relationships


Information Available








Frates, James E




70


Taunton, MA
Whitinsville, MA
Raynham, MA
Worcester, MA





Manseau, Melaine A

Frates, Christopher J

Frates, Ernest

Frates, Lori J

Frates, Lori



Get Full Report

Report can contain

Profile
Phone number
Address








Frates, James







Fall River, MA





Frates, David Andrew

Frates, Maria M



Get Full Report

Report can contain

Profile
Phone number
Address








Frates, James




69


New Bedford, MA
South Dartmouth, MA





Frates, Scott J

Frates, Karen L

Frates, Judith M

Frates, Charlotte B

Frates, Deborah Ann

Frates, Judith M

Frates, Karen L



Get Full Report

Report can contain

Profile
Phone number
Address








Frates, James M







Barrington, RI







Get Full Report

Report can contain

Profile
Phone number
Address








Dafrates, James J

Possible Aka's:
Frates, J
Frates, James J
Frates, Jas J
Frates, Jesse J

Find out more



64


Coventry, RI
East Greenwich, RI







Get Full Report

Report can contain

Profile
Phone number
Address








Frates, James J

Possible Aka's:
Jfrates, James

Find out more



43


Assonet, MA
North Attleboro, MA
Tiverton, RI
East Freetown, MA
Fall River, MA





Frates, David Andrew

Frates, Maria M

Frates, Carol W

Frates, Jas

Beaulieu, Lisa A

Frates, David A



Get Full Report

Report can contain

Profile
Phone number
Address








Frates, James Michael

Possible Aka's:
Frates, J

Find out more



45


Lisbon, CT
Pawcatuck, CT
Waterford, CT





Frates, Patricia Ann

Frates, William L

Wilcox, Crystal A

Frates, Crystal A

Garza, Susan A



Get Full Report

Report can contain

Profile
Phone number
Address








Fratesi, James J

Possible Aka's:
Frates, James J
Fratesi, James

Find out more



69


Rahway, NJ
Linden, NJ
Milltown, NJ





Fratesi, Helen R

Eldridge, Lisa R



Get Full Report

Report can contain

Profile
Phone number
Address








Frates, James Matthew

Possible Aka's:
Frates, James R

Find out more



44


Cambridge, MA
Wellesley, MA
Boston, MA
Wellesley Hills, MA
Kissimmee, FL
Barrington, RI
San Francisco, CA
New York, NY





Frates, Elizabeth Pegg



Get Full Report

Report can contain

Profile
Phone number
Address








Frates, James R







Sandy, UT





Frates, Patricia A



Get Full Report

Report can contain

Profile
Address








De Frates, Frates James L

Possible Aka's:
De, Frates /Tr
De, Frates Harriett
De, Frates James
De, James Louis
De Frates, Frates James
De Frates, James L
Defrates, James Louis

Find out more



78


Newbury Park, CA
Carpinteria, CA
Thousand Oaks, CA
Sylmar, CA





Defrates, Harriett A

De, Frates Harriett

Defrates, Riett A

Defrates, Es Louis

Defrates, Christopher J

Defrates, H A

Defrates, James



Get Full Report

Report can contain

Profile
Phone number
Address








Frates, Jamie Sue

Possible Aka's:
Cook, Jamie S
Fratef, J F
Fratef, Jamie S
Frates, James C
Frates, James F

Find out more



56


Sacramento, CA
Chino Hills, CA





Frates, Robert Allen

Frates, Haley E

Fratef, Jf

Frates, Robt Allen



Get Full Report

Report can contain

Profile
Phone number
Address








Frates, James Daniel




55


Sebastopol, CA
Goleta, CA
Healdsburg, CA
Santa Barbara, CA





Frates, Margaret A

Frates, Peter Stephen

Frates, Jennifer R

Frates, Diana Lynn

Frates, Jude R



Get Full Report

Report can contain

Profile
Phone number
Address








Frates, James E







Jacksonville Beach, FL
Jacksonville, FL
Neptune Beach, FL







Get Full Report

Report can contain

Profile
Address








Frates, James E

Possible Aka's:
Frates, Jim E

Find out more



73


Kenai, AK







Get Full Report

Report can contain

Profile
Phone number
Address








Frates, Bradley James

Possible Aka's:
Frates, B
Frates, Jared B
Frates, James E
Frates, Brad J

Find out more



49


Kenai, AK







Get Full Report

Report can contain

Profile
Phone number
Address








Frates, James E




70


Taunton, MA
East Taunton, MA





Frates, Roberta M



Get Full Report

Report can contain

Profile
Address








De, Frates James M

Possible Aka's:
De, Frates

Find out more



86









Get Full Report

Report can contain

Profile








De, Frates Harriett

Possible Aka's:
De, Frates James
De, Frates James L
De, James L
De Frates, James L
De Frates, Jas L
Defrates, James L

Find out more






Newbury Park, CA
Carpinteria, CA





Defrates, Harriett A

Defrates, Frates Jamesl

Defrates, Christopher J

Defrates, H A

Defrates, Es Louis

Defrates, Riett A

Defrates, James



Get Full Report

Report can contain

Profile
Phone number
Address








Frates, James














Get Full Report

Report can contain

Profile








Frates, James E




74


Saint Augustine, FL
Jacksonville, FL
Metairie, LA







Get Full Report

Report can contain

Profile
Address








Frates, James







Guerneville, CA







Get Full Report

Report can contain

Profile
Phone number
Address








Frates, James F




81


Taunton, MA







Get Full Report

Report can contain

Profile
Address








Frates, James




82


Salt Lake City, UT
Holladay, UT





Frates, Patricia A



Get Full Report

Report can contain

Profile
Address








De Frates, Frates James P







Audubon, NJ





Defrates, James



Get Full Report

Report can contain

Profile
Phone number
Address








Frates, James A







Taunton, MA





Frates, Mabel H



Get Full Report

Report can contain

Profile
Phone number
Address








Frates, James







Dartmouth, MA





Frates, Judith M

Frates, Scott J

Frates, Charlotte M

Frates, Deborah A



Get Full Report

Report can contain

Profile
Address








Frates, James E







East Taunton, MA







Get Full Report

Report can contain

Profile
Address








Frates, James D














Get Full Report

Report can contain

Profile
Phone number
















Copyright © 2007 - 2017
Veromi All rights reserved.



Login
| Search
| Bookmark
| Contact Us
| Terms & Conditions 
| Help
| Site Map
| People
| People Search Directory
| Articles
| Answering Service
| People Search
















Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft















Background Checks and Public Records Search - Truthfinder








 


















Call Toll Free!  (800) 699-8081



 Public Records Search
Social Media, Photos, Police Records, Background Checks, Contact Information and Much More!









START HERE - Try searching a friend, relative, celebrity, yourself, or someone else you might know...



First Name:





Last Name:





City:





State:


All States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
District Of Columbia
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virgin Islands
Virginia
Washington
West Virginia
Wisconsin
Wyoming





This is me
Searching for yourself?




Search





  This secure connection is confirmed




We're Very Popular















What Our Happy Users Are Saying




"TruthFinder.com is freakishly accurate… Really scary how much info is out there." -Zac K.


"You found an old friend for me. Thank you." -Nancy V.


"TruthFinder is an excellent site for finding out about someone." -Sherrie F.


"This site is so wonderful. I found my lost godchildren and their mom. Thank you so much." -Lawrence W.


"This is one way to really know a potential date." -Charmaine R.


"Your service is more than perfect. It is a blessing. Thank you for the very hard work that you do." -Richard B.


"Truthfinder is a very accurate updated system. Their information is proper. And can be very helpful too." -Juan M.









Notice
This site contains REAL police records (court records of driving citations, speeding tickets, felonies, misdemeanors, sexual offenses, mugshots, etc.), background reports, photos, court documents, address information, phone numbers, and much more. Please BE CAREFUL when conducting a search and ensure all the information you enter is accurate.
Learning the truth about the history of your family and friends can be shocking, so please be cautious when using this tool.
TruthFinder does not provide consumer reports and is not a consumer reporting agency. We provide a lot of sensitive information that can be used to satisfy your curiosity, protect your family, and find the truth about the people in your life. You may not use our service or the information it provides to make decisions about consumer credit, employers, insurance, tenant screening, or any other purposes that would require FCRA compliance.
I Understand


Help Us Refine Your Results
Select Your Gender



Male



Female

NEXT

Skip






















james frates - WOW.com - Web Results










AOL Search
Skip over navigation

















Search the Web



























Web





Images


Images




Reference


Reference










James Frates (Found) | PublicRecordsNow.com



Ad
 ·
PublicRecordsNow.com/​James Frates



Instant-Address, Phone, Age & More James Frates- Search Now





Background Check Instant



Criminal?




People Search NOW



Reverse Phone Search





James Frates Revealed - Want Info on James Frates?



Ad
 ·
Records.TruthFinder.com



Want Info on James Frates? Just Search A Name and State.




We Found James Frates - Searching for James Frates?



Ad
 ·
www.Spokeo.com/​James Frates



Searching for James Frates? Get Phone #,  Address, Pics & More!





Social Network Search



Search Public Records



White Pages Directory



Free People Search





We Found James Frates | PrivateEye.com



Ad
 ·
PrivateEye.com/​James Frates



Instant-Address, Phone, Age & More James Frates- Search Free Now



Web Results

James Frates | Whitepages

www.whitepages.com/name/James-Frates


View phone, address history, email, public records for the 11 people named James Frates. Whitepages is the most trusted directory.


James Frates Profiles | Facebook

https://www.facebook.com/public/James-Frates


View the profiles of people named James Frates. Join Facebook to connect with James Frates and others you may know. Facebook gives people the power to...


Top 4 James Frates profiles | LinkedIn

https://www.linkedin.com/pub/dir/James/Frates


View the profiles of professionals named James Frates on LinkedIn. There are 4 professionals named James Frates, who use LinkedIn to exchange information, ideas, and ...


James Frates's Phone Number, Email, Address - Spokeo

https://www.spokeo.com/James-Frates


50 records for James Frates. Find James Frates's phone, address, and email on Spokeo, the leading online directory


James Frates | LinkedIn

https://www.linkedin.com/in/james-frates-b656a81a


View James Frates’ professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like James Frates discover inside ...


James Frates - Historical records and family trees ...

https://www.myheritage.com/names/james_frates


Explore historical records and family tree profiles about James Frates on MyHeritage, the world's family history network.


James Frates | Facebook

https://www.facebook.com/james.frates.3/photos


James Frates is on Facebook. Join Facebook to connect with James Frates and others you may know. Facebook gives people the power to share and makes the...


James M. Frates - Executive Bio, Compensation History, and ...

people.equilar.com/bio/james-frates-alkermes-plc/salary/21297


View James M. Frates, Senior Vice President, Chief Financial Officer and Treasurer at Alkermes, executive profile on Equilar Atlas to see current salary at Alkermes ...


James M. Frates - Executive Bio & Compensation History

executives.findthecompany.com/l/956/James-M-Frates


Find compensation and employment information for James M. Frates (Alkermes), including salary, stock awards, and previous employers.


James Frates at MyLife.com® - View 9 Results Found

https://www.mylife.com/james-frates


James Frates - Search matches by state, province, places worked, relatives, age & more at MyLife! Find people in the United States named James Frates










James Frates (Found) | PublicRecordsNow.com



Ad
 ·
PublicRecordsNow.com/​James Frates



Instant-Address, Phone, Age & More James Frates- Search Now





Background Check Instant



Criminal?




People Search NOW



Reverse Phone Search





James Frates Revealed - Want Info on James Frates?



Ad
 ·
Records.TruthFinder.com



Want Info on James Frates? Just Search A Name and State.




We Found James Frates - Searching for James Frates?



Ad
 ·
www.Spokeo.com/​James Frates



Searching for James Frates? Get Phone #,  Address, Pics & More!





Social Network Search



Search Public Records



White Pages Directory



Free People Search





We Found James Frates | PrivateEye.com



Ad
 ·
PrivateEye.com/​James Frates



Instant-Address, Phone, Age & More James Frates- Search Free Now


12345Next






Answers







Ice Bucket Challenge



money for charity are unclear and have been attributed to multiple sources. The most commonly accepted origin credits Pete Frates, a Boston College...

more






Atanasiu di Iaci



Frate Atanasiu di Iaci or Athanasiu da Jaci was a Benedictine monk and historiographer from Aci. He wrote Vinuta di lu re Japicu in Catania (c.1295), a...

more






Tendring District Council election, 2011



Holland and Kirby Homelands Lawford Little Clacton and Weeley Manningtree, Mistley, Little Bentley and Tendring Peter Bruff Pier Ramsey and Parkeston...

more



















Search the Web

















© AOL Inc. All Rights Reserved.Privacy
 | Terms of Use
 | About our Ads
 | Preferences
 | Contact Us
 | Powered by Bing™

Part of the AOL Search Network.








